Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Articles

Glucose Consumption by Transplanted Tumors in Vivo

Pietro M. Gullino, Flora H. Grantham and Anita H. Courtney
Pietro M. Gullino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Flora H. Grantham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anita H. Courtney
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published June 1967
  • Article
  • Info & Metrics
  • PDF
Loading

Summary

The relationship between availability and utilization of glucose and production of lactate was studied in vivo in Walker carcinoma 256, Hepatoma 5123, and Fibrosarcoma 4956 transplanted in rats. The tumors utilized 0.96, 0.55, and 0.45 gm of glucose/hr/100 gm wet tumor weight, respectively, corresponding to 28%, 23%, and 32% of the amount supplied. About 35% of the glucose consumed was eliminated as lactate regardless of the tumor type. In normoglycemia, the amount of glucose consumed and glycolyzed was directly related to the glucose available which decreased per unit weight as the tumor size increased. During hyperglycemia, produced either by dextrose injections or diabetes, the tumors increased glucose utilization. The increase was maximum during the first few hours; then a “saturation” level was reached. When hyperglycemia was prolonged for several days, carcinomas and hepatomas consistently consumed about ½ more glucose; however, fibrosarcomas reduced their consumption by about 30%. Insulin did not improve glucose consumption of tumors either in normal or diabetic rats. Actually, the overall utilization was reduced because the plasma level of glucose in the host was lowered by insulin. Hypoglycemia or injections of 2-deoxy-d-glucose reduced glucose consumption, and in vivo the tumors were unable to compensate for this decrease by removing more glucose from the blood. The vascular walls of neoplastic vessels maintained a sharp concentration difference between glucose in plasma and in the interstitial fluid, with the fluid surrounding the neoplastic cells containing only a few mg percent of free glucose and practically all of the glucose passing through the vascular walls being rapidly consumed. During hyperglycemia the concentration difference disappeared and the vascular and interstitial compartments had about equal concentrations of glucose. Normo- or hypoglycemia restored the concentration gradient for glucose between the vascular and the interstitial compartment. The time needed to complete the restoration was longer after prolonged hyperglycemia. The regulation of the glucose transfer by the vascular wall of neoplastic vessels is postulated.

Footnotes

    • Received September 30, 1966.
    • Accepted January 11, 1967.
    • ©1967 American Association for Cancer Research.
    PreviousNext
    Back to top
    June 1967
    Volume 27, Issue 6 Part 1
    • Table of Contents
    • Table of Contents (PDF)
    • Back Matter (PDF)
    • Editorial Board (PDF)
    • Front Matter (PDF)

    Sign up for alerts

    Open full page PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Cancer Research article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Glucose Consumption by Transplanted Tumors in Vivo
    (Your Name) has forwarded a page to you from Cancer Research
    (Your Name) thought you would be interested in this article in Cancer Research.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Glucose Consumption by Transplanted Tumors in Vivo
    Pietro M. Gullino, Flora H. Grantham and Anita H. Courtney
    Cancer Res June 1 1967 (27) (6 Part 1) 1031-1040;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Glucose Consumption by Transplanted Tumors in Vivo
    Pietro M. Gullino, Flora H. Grantham and Anita H. Courtney
    Cancer Res June 1 1967 (27) (6 Part 1) 1031-1040;
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
    • Info & Metrics
    • PDF
    Advertisement

    Related Articles

    Cited By...

    More in this TOC Section

    • The Prizes
    • Mammary Gland Development, Reproductive History, and Breast Cancer Risk
    • Pax Genes and Their Role in Organogenesis
    Show more Articles
    • Home
    • Alerts
    • Feedback
    • Privacy Policy
    Facebook  Twitter  LinkedIn  YouTube  RSS

    Articles

    • Online First
    • Current Issue
    • Past Issues
    • Meeting Abstracts

    Info for

    • Authors
    • Subscribers
    • Advertisers
    • Librarians

    About Cancer Research

    • About the Journal
    • Editorial Board
    • Permissions
    • Submit a Manuscript
    AACR logo

    Copyright © 2021 by the American Association for Cancer Research.

    Cancer Research Online ISSN: 1538-7445
    Cancer Research Print ISSN: 0008-5472
    Journal of Cancer Research ISSN: 0099-7013
    American Journal of Cancer ISSN: 0099-7374

    Advertisement